Exenatide Improves Glucose Homeostasis and Prolongs Survival in a Murine Model of Dilated Cardiomyopathy
暂无分享,去创建一个
P. Hruz | Kai-Chien Yang | A. Tzekov | P. Jay | A. Kovács | A. Vyas | Dennis Woo
[1] J. Holst,et al. Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances , 2010, Current opinion in endocrinology, diabetes, and obesity.
[2] B. Green,et al. Emerging cardiovascular actions of the incretin hormone glucagon‐like peptide‐1: potential therapeutic benefits beyond glycaemic control? , 2009, British journal of pharmacology.
[3] M. Sugimachi,et al. Metformin Prevents Progression of Heart Failure in Dogs: Role of AMP-Activated Protein Kinase , 2009, Circulation.
[4] D. Yellon,et al. GLP-1 therapy: beyond glucose control. , 2008, Circulation. Heart failure.
[5] Hong Zheng,et al. Cardiac Glucose Uptake and Suppressed Expression/Translocation of Myocardium Glucose Transport-4 in Dogs Undergoing Ischemia-Reperfusion , 2008, Experimental biology and medicine.
[6] R. Schwenk,et al. Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease. , 2008, Cardiovascular research.
[7] I. Poornima,et al. Chronic Glucagon-Like Peptide-1 Infusion Sustains Left Ventricular Systolic Function and Prolongs Survival in the Spontaneously Hypertensive, Heart Failure–Prone Rat , 2008, Circulation. Heart failure.
[8] P. Hruz,et al. HIV protease inhibitors that block GLUT4 precipitate acute, decompensated heart failure in a mouse model of dilated cardiomyopathy , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] R. Witteles,et al. Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. , 2008, Journal of the American College of Cardiology.
[10] J. McGill,et al. Fatty Acids and Insulin Modulate Myocardial Substrate Metabolism in Humans With Type 1 Diabetes , 2008, Diabetes.
[11] L. Opie,et al. Metabolic mechanisms in heart failure. , 2007, Circulation.
[12] Yunyu Zhang,et al. Protective effects of exercise and phosphoinositide 3-kinase(p110α) signaling in dilated and hypertrophic cardiomyopathy , 2007, Proceedings of the National Academy of Sciences.
[13] R. Shannon,et al. Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure. , 2006, Journal of cardiac failure.
[14] G. Lopaschuk,et al. AMPK alterations in cardiac physiology and pathology: enemy or ally? , 2006, The Journal of physiology.
[15] W. Pu,et al. Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase. , 2006, Journal of cardiac failure.
[16] D. Kempf,et al. Metabolism and Disposition of the HIV-1 Protease Inhibitor Lopinavir (ABT-378) Given in Combination with Ritonavir in Rats, Dogs, and Humans , 2004, Pharmaceutical Research.
[17] P. Sen,et al. Involvement of the Akt/PKB signaling pathway with disease processes , 2003, Molecular and Cellular Biochemistry.
[18] M. Morissette,et al. Upregulation of GLUT1 expression is necessary for hypertrophy and survival of neonatal rat cardiomyocytes. , 2003, Journal of molecular and cellular cardiology.
[19] D. Drucker,et al. Cardiac function in mice lacking the glucagon-like peptide-1 receptor. , 2003, Endocrinology.
[20] R. Lerch,et al. Postinfarction heart failure in rats is associated with upregulation of GLUT-1 and downregulation of genes of fatty acid metabolism. , 2001, Cardiovascular research.
[21] D. Kempf,et al. Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans. , 1997, Drug metabolism and disposition: the biological fate of chemicals.
[22] M. Cawthorne,et al. Quantification in vivo of the effects of insulin on glucose utilization in individual tissues of warm- and cold-acclimated rats. , 1986, The Biochemical journal.
[23] C. J. Goodner,et al. A (3H)2-Deoxyglucose Method for Comparing Rates of Glucose Metabolism and Insulin Responses Among Rat Tissues In Vivo: Validation of the Model and the Absence of an Insulin Effect on Brain , 1984, Diabetes.
[24] P. Mulder,et al. Heart rate slowing for myocardial dysfunction/heart failure. , 2006, Advances in cardiology.
[25] M. Mocanu,et al. Glucagon Like Peptide-1 is Protective Against Myocardial Ischemia/Reperfusion Injury when Given Either as a Preconditioning Mimetic or at Reperfusion in an Isolated Rat Heart Model , 2005, Cardiovascular Drugs and Therapy.
[26] D. Hardie,et al. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. , 2005, Cell metabolism.
[27] R. Shannon,et al. Insulin resistance in dilated cardiomyopathy. , 2003, Reviews in cardiovascular medicine.
[28] B. Rodrigues,et al. Myocardial substrate metabolism: implications for diabetic cardiomyopathy. , 1995, Journal of molecular and cellular cardiology.